ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 46.9%, free cash flow grew 656.0% and total debt fell 7.96%, each against the same quarter a year earlier.
Follow ICUI
ICU Medical, Inc. (ICUI) P/E ratio
As of 16 October 2026, ICU Medical, Inc. (ICUI) trades at a P/E ratio of 136×. Over the past ten years it has ranged from 0.0× (December 2025) to 7,927× (January 2026); the current reading is higher than 90% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 7,134× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 48.7× | (5.71%) |
| FY2020 | 51.7× | 35.62% |
| FY2019 | 38.1× | (76.43%) |
| FY2018 | 162× | 172.15% |
| FY2017 | 59.4× | 51.78% |
| FY2016 | 39.1× | (1.42%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 122× | 76.89% |
| Mar 2026 | 69.1× | (99.03%) |
| Dec 2025 | 7,134× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| STVN Stevanato Group S.p.A. compare | 33.8× |
| MMSI Merit Medical Systems, Inc. compare | 36.4× |
| NVST Envista Holdings Corporation compare | 38.8× |
| ICUI ICU Medical, Inc. | 136× |
| ATRC AtriCure, Inc. compare | 259× |
| WRBY Warby Parker Inc. compare | 334× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)